Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer

This study was designed to evaluate the efficacy and tolerability of a weekly schedule of epirubicin in combination with docetaxel in the first-line treatment of patients with metastatic breast cancer (MBC). A total of 43 women with MBC not previously treated with chemotherapy for metastatic disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamucci, T, D'Ottavio, A M, Magnolfi, E, Barduagni, M, Vaccaro, A, Sperduti, I, Moscetti, L, Belli, F, Meliffi, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360453/
https://www.ncbi.nlm.nih.gov/pubmed/17940499
http://dx.doi.org/10.1038/sj.bjc.6603982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360453/
https://www.ncbi.nlm.nih.gov/pubmed/17940499
http://dx.doi.org/10.1038/sj.bjc.6603982

Ejemplares similares